$1.36
-0.05-3.55%
In chiusura: -
$1.34
-0.02-1.46%
After hour: Aug 15, 6:13 PM EDT
Redhill Biopharma segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Redhill Biopharma utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RDHL | Redhill Biopharma | $0.00 | — | — | — | $2.57M | — | — | — | 08/28/2025 | |
RDHL | Redhill Biopharma | $0.01 | — | $0.00 | — | $6.53M | — | $8.04M | — | 04/10/2025 | |
RDHL | Redhill Biopharma | $0.04 | — | $0.00 | — | $5.39M | — | $2.57M | — | 08/29/2024 | |
RDHL | Redhill Biopharma | -$3.00 | — | $0.25 | — | $61.80M | — | $6.53M | — | 04/08/2024 | |
RDHL | Redhill Biopharma | -$20.00 | — | $2.25 | — | $18.35M | — | $1.80M | — | 08/17/2023 | |
RDHL | Redhill Biopharma | $1.00 | — | -$1.25 | — | $13.10M | — | $3.60M | — | 06/12/2023 | |
RDHL | Redhill Biopharma | -$500.00 | — | $0.00 | — | $22.07M | $18.10M | $12.80M | -29.29% | 04/28/2023 | |
RDHL | Redhill Biopharma | -$50.00 | — | -$60.00 | — | $21.61M | $21.24M | $17.55M | — | 11/29/2022 | |
RDHL | Redhill Biopharma | -$60.00 | — | -$20.00 | — | $21.50M | — | $18.35M | — | 11/07/2022 | |
RDHL | Redhill Biopharma | -$50.00 | -$230.00 | -$300.00 | -30.43% | $20.57M | $24.30M | $18.24M | -24.95% | 06/23/2022 | |
RDHL | Redhill Biopharma | -$70.00 | -$330.00 | -$500.00 | -51.52% | $21.46M | $24.08M | $22.07M | -8.34% | 03/17/2022 | |
RDHL | Redhill Biopharma | -$50.00 | -$210.00 | -$500.00 | -138.10% | $20.94M | $24.52M | $21.61M | -11.87% | 11/30/2021 | |
RDHL | Redhill Biopharma | $40.00 | -$120.00 | -$60.00 | 50.00% | $20.90M | $25.02M | $21.50M | -14.06% | 08/26/2021 | |
RDHL | Redhill Biopharma | -$50.00 | -$340.00 | -$50.00 | 85.29% | $1.06M | $22.70M | $20.57M | -9.36% | 05/27/2021 | |
RDHL | Redhill Biopharma | $30.00 | -$240.00 | -$70.00 | 70.83% | $1.59M | $26.03M | $21.46M | -17.55% | 03/18/2021 | |
RDHL | Redhill Biopharma | -$30.00 | -$160.00 | -$50.00 | 68.75% | $1.40M | $25.37M | $20.94M | -17.45% | 11/12/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q1 | 2022-06-23 | $-300.00 | $-230.00 | -30.4 % |
Q4 | 2022-03-17 | $-500.00 | $-330.00 | -51.5 % |
Q3 | 2021-11-30 | $-500.00 | $-210.00 | -138.1 % |
Q2 | 2021-08-26 | $-60.00 | $-120.00 | 50.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q4 | 2023-04-28 | $12.80M | $18.10M | -29.3 % |
Q1 | 2022-06-23 | $18.24M | $24.30M | -24.9 % |
Q4 | 2022-03-17 | $22.07M | $24.08M | -8.34 % |
Q3 | 2021-11-30 | $21.61M | $24.52M | -11.9 % |
Si prevede che Redhill Biopharma (RDHL) fornisca risultati il agosto 28, 2025. Gli ultimi risultati sono stati pubblicati il aprile 10, 2025 per il FY.
L'EPS effettivo era $0.00, che centrato la stima di $0.00.
Le entrate effettive sono state $8M, che superato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.